Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytomegalovirus antigen IE1 (Immediate Early 1 protein) is a 72 kDa viral protein expressed immediately upon infection with human cytomegalovirus (HCMV). It functions as a key regulator of both viral and cellular transcription, interacting with host chromatin and disrupting nuclear domain 10 (ND10) compartments. IE1 plays a critical role in immune evasion by inhibiting type I interferon-dependent signaling pathways and antagonizing intrinsic cellular defenses. It is a major target for CD8+ T cell responses and is used as an early marker for active CMV infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytomegalovirus antigen IE1.